Dominican Republic Redefines Winter Getaway
Feb 07, 2018 13:01 pm UTC| Business
SANTO DOMINGO, DOMINICAN REPUBLIC, Feb. 07, 2018 -- Record low temperatures have put this winter on track to be the coldest in the last decade. With seven weeks until spring, now is the perfect time to plan a winter...
Feb 07, 2018 13:01 pm UTC| Business
CAMPBELL, Calif., Feb. 07, 2018 -- Bitglass, the Next-Gen Cloud Access Security Broker (CASB) company, today announced the results of its latest research, Malware, P.I., Tracking Cloud Infections. While cloud and mobile...
Melissa Launches Melissa Direct, Comprehensive Data Quality Site for Marketers
Feb 07, 2018 13:01 pm UTC| Business
RANCHO SANTA MARGARITA, Calif., Feb. 07, 2018 -- Melissa, a leading provider of global contact data quality and identity verification solutions, today announced Melissa Direct, its one-stop shop for list hygiene, data...
Uptick Newswire’s “Stock Day” Podcast Hosts Salvador Rosillo, CEO of HempAmericana, Inc.
Feb 07, 2018 13:01 pm UTC| Business
PHOENIX, Feb. 07, 2018 -- HempAmericana, Inc. (OTC:HMPQ) today announced the release of CEO, Salvador Rosillo’s interview on Uptick Newswire’s “Stock Day” Podcast with Everett Jolly. HempAmericana recently completed...
Caladrius Biosciences to Present at the 2018 BIO CEO & Investor Conference
Feb 07, 2018 13:01 pm UTC| Business
BASKING RIDGE, N.J., Feb. 07, 2018 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and...
Solar Senior Capital Ltd. Announces Monthly Distribution of $0.1175 Per Share for February 2018
Feb 07, 2018 13:01 pm UTC| Business
NEW YORK, Feb. 07, 2018 -- Solar Senior Capital Ltd. (the “Company”) (NASDAQ:SUNS) today declared a distribution of $0.1175 per share for the month of February 2018. The distribution is payable on March 1, 2018 to...
Mersana Therapeutics to Present at Upcoming Investor Conferences
Feb 07, 2018 13:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 07, 2018 -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Biden administration tells employers to stop shackling workers with ‘noncompete agreements’
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects